DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
LERSIVIRINE
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
LERSIVIRINE
×
Maximum Phase:
2
First Approval:
None
UNII:
R3ZGC15A9A
Molecule Type:
Small molecule
Molecular Formula:
C17H18N4O2
Molecular Weight:
310.36
AlogP:
2.54
PSA:
94.86
HBD:
1.0
HBA:
#RotB:
6.0
Source:
PER977
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PER977
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
POZANICLINE
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Attention Deficit Disorder with Hyperactivity; Tobacco Use Disorder
Neuronal acetylcholine receptor; alpha6/beta2 partial agonist
POZANICLINE
×
Maximum Phase:
2
First Approval:
None
UNII:
CL2002R563
Molecule Type:
Small molecule
Molecular Formula:
C11H16N2O
Molecular Weight:
192.26
AlogP:
1.52
PSA:
34.15
HBD:
1.0
HBA:
#RotB:
3.0
Source:
PYRUVATE
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Prostatic Neoplasms
Unknown
PYRUVATE
×
Maximum Phase:
2
First Approval:
None
UNII:
8558G7RUTR
Molecule Type:
Small molecule
Molecular Formula:
C3H4O3
Molecular Weight:
88.06
AlogP:
-0.34
PSA:
54.37
HBD:
1.0
HBA:
#RotB:
1.0
Source:
PF-03654746
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Schizophrenia; Attention Deficit Disorder with Hyperactivity; Rhinitis, Allergic, Seasonal; Tourette Syndrome
Histamine H3 receptor antagonist
PF-03654746
×
Maximum Phase:
2
First Approval:
None
UNII:
G3QE979K1X
Molecule Type:
Small molecule
Molecular Formula:
C18H24F2N2O
Molecular Weight:
322.4
AlogP:
3.13
PSA:
32.34
HBD:
1.0
HBA:
#RotB:
5.0
Source:
DNK333
2
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic; Irritable Bowel Syndrome
Neurokinin 1 receptor antagonist
DNK333
×
Maximum Phase:
2
First Approval:
None
UNII:
G9BL4978MZ
Molecule Type:
Small molecule
Molecular Formula:
C27H25Cl2F6N3O3
Molecular Weight:
624.41
AlogP:
6.06
PSA:
78.51
HBD:
2.0
HBA:
#RotB:
7.0
Source:
LUMICITABINE
2
Small molecule
Investigational
Unknown
Unknown
Respiratory Syncytial Virus Infections
RNA-directed RNA polymerase L inhibitor
LUMICITABINE
×
Maximum Phase:
2
First Approval:
None
UNII:
BNW5PQ52G1
Molecule Type:
Small molecule
Molecular Formula:
C18H25ClFN3O6
Molecular Weight:
433.86
AlogP:
1.44
PSA:
122.74
HBD:
1.0
HBA:
#RotB:
7.0
Source:
PHOSPHOCREATINE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PHOSPHOCREATINE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MK-0773
2
Small molecule
Investigational
Unknown
Unknown
Sarcopenia
Androgen Receptor modulator
MK-0773
×
Maximum Phase:
2
First Approval:
None
UNII:
5730VNW22X
Molecule Type:
Small molecule
Molecular Formula:
C27H34FN5O2
Molecular Weight:
479.6
AlogP:
4.13
PSA:
90.98
HBD:
2.0
HBA:
#RotB:
3.0
Source:
ACALISIB
2
Small molecule
Investigational
Unknown
Unknown
Hematologic Neoplasms
PI3-kinase p110-delta subunit inhibitor
ACALISIB
×
Maximum Phase:
2
First Approval:
None
UNII:
OVW60IDW1D
Molecule Type:
Small molecule
Molecular Formula:
C21H16FN7O
Molecular Weight:
401.41
AlogP:
3.36
PSA:
101.38
HBD:
2.0
HBA:
#RotB:
4.0
Source:
DORAMAPIMOD
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Psoriasis
MAP kinase p38 alpha inhibitor
DORAMAPIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
HO1A8B3YVV
Molecule Type:
Small molecule
Molecular Formula:
C31H37N5O3
Molecular Weight:
527.67
AlogP:
5.99
PSA:
80.65
HBD:
2.0
HBA:
#RotB:
7.0
Source:
MERIMEPODIB
2
Small molecule
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome
Inosine-5'-monophosphate dehydrogenase 1 inhibitor
MERIMEPODIB
×
Maximum Phase:
2
First Approval:
None
UNII:
2ZL2BA06FU
Molecule Type:
Small molecule
Molecular Formula:
C23H24N4O6
Molecular Weight:
452.47
AlogP:
4.01
PSA:
123.95
HBD:
3.0
HBA:
#RotB:
7.0
Source:
PRALICIGUAT
2
Small molecule
Investigational
Unknown
Unknown
Heart Failure
Soluble guanylate cyclase activator
PRALICIGUAT
×
Maximum Phase:
2
First Approval:
None
UNII:
R1S0H458SA
Molecule Type:
Small molecule
Molecular Formula:
C21H14F8N6O2
Molecular Weight:
534.37
AlogP:
4.59
PSA:
101.89
HBD:
2.0
HBA:
#RotB:
7.0
Source:
LCL-161
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Pancreatic Neoplasms; Breast Neoplasms; Multiple Myeloma; Polycythemia Vera; Primary Myelofibrosis
Unknown
LCL-161
×
Maximum Phase:
2
First Approval:
None
UNII:
6TNS415Y3P
Molecule Type:
Small molecule
Molecular Formula:
C26H33FN4O3S
Molecular Weight:
500.64
AlogP:
3.85
PSA:
91.4
HBD:
2.0
HBA:
#RotB:
8.0
Source:
IRSENONTRINE
2
Small molecule
Investigational
Unknown
Unknown
Dementia
Unknown
IRSENONTRINE
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C22H22N4O3
Molecular Weight:
390.44
AlogP:
3.53
PSA:
82.03
HBD:
1.0
HBA:
#RotB:
3.0
Source:
EKB-569
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
EKB-569
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FGF401
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular
Fibroblast growth factor receptor 4 inhibitor
FGF401
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALDUMASTAT
2
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis
Unknown
ALDUMASTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C20H24F2N4O3
Molecular Weight:
406.43
AlogP:
1.77
PSA:
81.75
HBD:
2.0
HBA:
#RotB:
5.0
Source:
Z160
2
Small molecule
Investigational
Unknown
Unknown
Neuralgia, Postherpetic; Radiculopathy
Voltage-gated N-type calcium channel alpha-1B subunit blocker
Z160
×
Maximum Phase:
2
First Approval:
None
UNII:
TX3R141LEP
Molecule Type:
Small molecule
Molecular Formula:
C32H32N2O
Molecular Weight:
460.62
AlogP:
6.14
PSA:
23.55
HBD:
0.0
HBA:
#RotB:
7.0
Source:
BINDARIT
2
Small molecule
Investigational
Unknown
Unknown
Coronary Restenosis; Diabetic Nephropathies
Unknown
BINDARIT
×
Maximum Phase:
2
First Approval:
None
UNII:
JQ11LH711M
Molecule Type:
Small molecule
Molecular Formula:
C19H20N2O3
Molecular Weight:
324.38
AlogP:
3.46
PSA:
64.35
HBD:
1.0
HBA:
#RotB:
6.0
Source:
AURICLOSENE
2
Small molecule
Investigational
Unknown
Unknown
Conjunctivitis, Bacterial; Conjunctivitis, Viral; Impetigo
Unknown
AURICLOSENE
×
Maximum Phase:
2
First Approval:
None
UNII:
BKR7Y95229
Molecule Type:
Small molecule
Molecular Formula:
C4H9Cl2NO3S
Molecular Weight:
222.09
AlogP:
1.26
PSA:
57.61
HBD:
1.0
HBA:
#RotB:
3.0
Source:
SURINABANT
2
Small molecule
Investigational
Unknown
Unknown
Obesity; Smoking Cessation
Cannabinoid CB1 receptor antagonist
SURINABANT
×
Maximum Phase:
2
First Approval:
None
UNII:
SF8R9VCB0X
Molecule Type:
Small molecule
Molecular Formula:
C23H23BrCl2N4O
Molecular Weight:
522.27
AlogP:
6.3
PSA:
50.16
HBD:
1.0
HBA:
#RotB:
5.0
Source:
PATIDEGIB HYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PATIDEGIB HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
ZL14FCA5PK
Molecule Type:
Small molecule
Molecular Formula:
C29H49ClN2O3S
Molecular Weight:
541.24
AlogP:
5.03
PSA:
67.43
HBD:
2.0
HBA:
#RotB:
2.0
Source:
LUNACALCIPOL
2
Small molecule
Investigational
Unknown
Unknown
Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Psoriasis; Renal Insufficiency, Chronic
Vitamin D receptor agonist
LUNACALCIPOL
×
Maximum Phase:
2
First Approval:
None
UNII:
XN4TL6M50Z
Molecule Type:
Small molecule
Molecular Formula:
C28H42O4S
Molecular Weight:
474.71
AlogP:
5.8
PSA:
74.6
HBD:
2.0
HBA:
#RotB:
5.0
Source:
QBW251
2
Small molecule
Investigational
Unknown
Unknown
Cystic Fibrosis; Pulmonary Disease, Chronic Obstructive
Cystic fibrosis transmembrane conductance regulator activator
QBW251
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DABUZALGRON
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Alpha-1a adrenergic receptor partial agonist
DABUZALGRON
×
Maximum Phase:
2
First Approval:
None
UNII:
LGX4GZ74WO
Molecule Type:
Small molecule
Molecular Formula:
C12H16ClN3O3S
Molecular Weight:
317.8
AlogP:
1.4
PSA:
79.79
HBD:
2.0
HBA:
#RotB:
5.0
Source:
BISEGLIPTIN
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Dipeptidyl peptidase IV inhibitor
BISEGLIPTIN
×
Maximum Phase:
2
First Approval:
None
UNII:
9U5KQ79OK6
Molecule Type:
Small molecule
Molecular Formula:
C18H26FN3O3
Molecular Weight:
351.42
AlogP:
1.69
PSA:
82.43
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CORTODOXONE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CORTODOXONE
×
Maximum Phase:
2
First Approval:
None
UNII:
WDT5SLP0HQ
Molecule Type:
Small molecule
Molecular Formula:
C21H30O4
Molecular Weight:
346.47
AlogP:
2.81
PSA:
74.6
HBD:
2.0
HBA:
#RotB:
2.0
Source:
VERUBULIN
2
Small molecule
Investigational
Unknown
Unknown
Brain Neoplasms; Neoplasms; Glioblastoma
Tubulin disrupting agent
VERUBULIN
×
Maximum Phase:
2
First Approval:
None
UNII:
X97O9FTB92
Molecule Type:
Small molecule
Molecular Formula:
C17H17N3O
Molecular Weight:
279.34
AlogP:
3.71
PSA:
38.25
HBD:
0.0
HBA:
#RotB:
3.0
Source:
TRELANSERIN
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Serotonin 1b (5-HT1b) receptor antagonist
TRELANSERIN
×
Maximum Phase:
2
First Approval:
None
UNII:
QUD44MBL5S
Molecule Type:
Small molecule
Molecular Formula:
C24H24FN5O2S
Molecular Weight:
465.55
AlogP:
2.6
PSA:
84.46
HBD:
1.0
HBA:
#RotB:
6.0
Source:
PIPENDOXIFENE
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Unknown
PIPENDOXIFENE
×
Maximum Phase:
2
First Approval:
None
UNII:
TPC5Q8496G
Molecule Type:
Small molecule
Molecular Formula:
C29H32N2O3
Molecular Weight:
456.59
AlogP:
5.94
PSA:
57.86
HBD:
2.0
HBA:
#RotB:
7.0
Source:
GSK-1521498
2
Small molecule
Investigational
Unknown
Unknown
Alcoholism; Obesity
Mu opioid receptor antagonist
GSK-1521498
×
Maximum Phase:
2
First Approval:
None
UNII:
W0UTB622GK
Molecule Type:
Small molecule
Molecular Formula:
C24H20F2N4
Molecular Weight:
402.45
AlogP:
4.67
PSA:
53.6
HBD:
2.0
HBA:
#RotB:
5.0
Source:
L-EFLORNITHINE HYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
L-EFLORNITHINE HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
UO07O10TCJ
Molecule Type:
Small molecule
Molecular Formula:
C6H13ClF2N2O2
Molecular Weight:
218.63
AlogP:
-0.23
PSA:
89.34
HBD:
3.0
HBA:
#RotB:
5.0
Source:
GS-0976
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GS-0976
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IBERDOMIDE
2
Small molecule
Investigational
Unknown
Unknown
Renal Insufficiency; Multiple Myeloma
CRL4(CRBN) E3 ubiquitin ligase modulator
IBERDOMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
8V66F27X44
Molecule Type:
Small molecule
Molecular Formula:
C25H27N3O5
Molecular Weight:
449.51
AlogP:
1.86
PSA:
88.18
HBD:
1.0
HBA:
#RotB:
6.0
Source:
1
2
…
117
118
119
120
121
122
123
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA